Mullerian Inhibiting Substance Ontogeny and its Modulation by Follicle-Stimulating Hormone in the Rat Testes*
- 1 October 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 127 (4) , 1825-1832
- https://doi.org/10.1210/endo-127-4-1825
Abstract
Mullerian Inhibiting Substance (MIS) production in rat testes from the late fetal to the adult period and its modulation by gonadotropins in neonatal testes were studied using immunohistochemistry, northern analysis, and a graded organ culture bioassay for MIS. The intense immunohistochemical staining for MIS seen in fetal and newborn testes began to decrease gradually after the third postnatal day, then decreased dramatically on the fifth postnatal day. MIS immunohistochemical activity was then present at a low level until about the 20th postnatal day, after which is was barely detectable. The testes from rats treated with FSH at birth showed a considerable drop in MIS immunohistochemical activity on the third postnatal day to 29% of control testes, and a less profound decrease on the second and fourth postnatal days to 46% and 61% of control, respectively; thereafter MIS levels were the same in treated and untreated animals. With shorter courses of FSH treatment, immunohistochemical staining showed less depression of MIS on the third day, and no difference by the fourth postnatal day, indicating that the inhibitory effect on testicular MIS production may require continued FSH exposure. Three-day testes that had been treated with FSH for 2-1/2 days had less MIS messenger RNA compared to control testes of the same age, suggesting that the inhibitory effect of FSH on MIS production could be transcriptionally mediated. In contrast LH treatment produced no difference in either messenger RNA expression or immunohistochemical staining for MIS. These findings suggested that FSH may be a modulator of MIS production in neonatal testes.This publication has 30 references indexed in Scilit:
- Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assayGynecologic Oncology, 1985
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985
- Immunocytochemical localization of Mullerian inhibiting substance in the rough endoplasmic reticulum and Golgi apparatus in Sertoli cells of the neonatal calf testis using a monoclonal antibody.Journal of Histochemistry & Cytochemistry, 1984
- Cyclic Adenosine 3′,5′-Monophosphate Modulation of Mullerian Duct Regression*Endocrinology, 1984
- Phosphorylation Events During Müllerian Duct RegressionScience, 1984
- Mullerian Inhibiting Substance Inhibits Colony Growth of a Human Ovarian Carcinoma Cell LineJournal of Clinical Endocrinology & Metabolism, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Inhibition of Müllerian Inhibiting Substance Secretion by FSHPediatric Research, 1979
- A graded organ culture assay for the detection of mullerian inhibiting substanceJournal of Surgical Research, 1977